Low hemoglobin levels: influence on tumor biology and radiotherapy treatment outcome

Molls, 1998, Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels, Strahlenther. Onkol., 174, 13 Dachs, 2000, Hypoxia modulated gene expression, Eur. J. Cancer, 36, 1649, 10.1016/S0959-8049(00)00159-3 Höckel, 1996, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res., 56, 4509 Vaupel, 2002, Hypoxia in breast cancer, Wien Med. Wschr, 152, 334, 10.1046/j.1563-258X.2002.02032.x Kelleher, 1996, Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats, Cancer Res., 56, 4728 Kelleher, 1998, Can erythropoietin improve tumor oxygenation?, Strahlenther. Onkol., 174, 20 Lavey, 1993, Influence of hematocrit on tumor oxygenation and sensitivity to radiation, Eur. J. Cancer, 29A, S216, 10.1016/0959-8049(93)91830-E Lavey, 1998, Clinical trial experience using erythropoietin during radiation therapy, Strahlenther. Onkol., 174, 24 Vaupel, 2001, Treatment resistance of solid tumors, Med. Oncol., 18, 243, 10.1385/MO:18:4:243 Becker, 2000, Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas, Int. J. Radiat. Oncol. Biol. Phys., 46, 459, 10.1016/S0360-3016(99)00384-3 Vaupel, 1991, Oxygenation of human tumors, Cancer Res., 51, 3316 Thews, 2001, Tumor hypoxia and anemia, Focus Anaemia Cancer, 2, 59 Fyles, 1998, Oxygenation predicts radiation response and survival in patients with cervix cancer, Radiother. Oncol., 48, 149, 10.1016/S0167-8140(98)00044-9 Knocke, 1999, Intratumoral pO2 measurements as predictive assay in the treatment of carcinoma of the uterine cervix, Radiother. Oncol., 53, 99, 10.1016/S0167-8140(99)00139-5 Vaupel, 1998, Oxygenation of human tumors, Strahlenther. Onkol., 174, 6 Strauss, 1999, Prognostic impact of changes in tumor tissue pO2 during early radiotherapy in cervical cancers, Int. J. Radiat. Oncol. Biol. Phys., 45, 364, 10.1016/S0360-3016(99)90437-6 Höckel, 2001, Tumor hypoxia, J. Natl. Cancer Inst., 93, 266, 10.1093/jnci/93.4.266 Höckel, 2001, Biological consequences of tumor hypoxia, Semin. Oncol., 28, 36, 10.1016/S0093-7754(01)90211-8 Coquelle, 1998, A new role for hypoxia in tumor progression, Mol. Cell, 2, 259, 10.1016/S1097-2765(00)80137-9 Reynolds, 1966, Genetic instability induced by the tumor microenvironment, Cancer Res., 56, 5754 Yuan, 1998, Mutagenesis induced by the tumor microenvironment, Mutat. Res., 400, 439, 10.1016/S0027-5107(98)00042-6 Rofstad, 2000, Microenvironment-induced cancer metastasis, Int. J. Radiat. Biol., 76, 589, 10.1080/095530000138259 Yuan, 2000, Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH, Cancer Res., 60, 4372 Graeber, 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors, Nature, 379, 88, 10.1038/379088a0 Hall EH, ed. Radiobiology for the Radiologist 4th ed. Philadelphia, PA, Lippincott, 1994. Kumar, 2000, Impact of anemia in patients with head and neck cancer, Oncologist, 5, 13, 10.1634/theoncologist.5-suppl_2-13 Hollaender, 1951, X-ray sensitivity of E. coli as modified by oxygen tension, Nature, 167, 103, 10.1038/167103a0 Teicher, 1995, Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia, Hematol. Oncol. Clin. North Am., 9, 475, 10.1016/S0889-8588(18)30105-9 Vaupel, 2002, Tumor hypoxia and therapeutic resistance, 127 Durand, 2001, Intermittent blood flow in solid tumors—an under-appreciated source of “drug resistance”, Cancer Metast. Rev., 20, 57, 10.1023/A:1013181107707 Teicher, 1981, Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells, Cancer Res., 41, 73 Teicher, 1990, Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FsallC murine fibrosarcoma, Cancer Res., 50, 3339 Teicher, 1994, Hypoxia and drug resistance, Cancer Metast. Rev., 13, 139, 10.1007/BF00689633 Weidner, 1993, Tumor angiogenesis correlates with metastasis in invasive prostate cancer, Am. J. Pathol., 143, 401 Weidner, 1991, Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma, N. Engl. J. Med., 324, 1, 10.1056/NEJM199101033240101 Mineta, 2000, Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas, Br. J. Cancer, 83, 775, 10.1054/bjoc.2000.1357 Smith, 2000, Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma, J. Clin. Oncol., 18, 2046, 10.1200/JCO.2000.18.10.2046 Klein, 2001, Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma, J. Clin. Endocrinol. Metab., 86, 656, 10.1210/jcem.86.2.7226 Dunst, 1999, Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?, Strahlenther. Onkol., 175, 93, 10.1007/BF02742340 Grogan, 1999, The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix, Cancer, 86, 1528, 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E Tarnawski, 1997, Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx, Int. J. Radiat. Oncol. Biol. Phys., 38, 1007, 10.1016/S0360-3016(97)00308-8 Egrie, 1986, Characterization and biological effects of recombinant human erythropoietin, Immunobiology, 172, 213, 10.1016/S0171-2985(86)80101-2 Abels, 1993, Erythropoietin for anemia in cancer patients, Eur. J. Cancer, 29A, S2, 10.1016/S0959-8049(05)80281-3 Glaspy, 1997, Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice, J. Clin. Oncol., 15, 1218, 10.1200/JCO.1997.15.3.1218 Demetri, 1998, Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study, J. Clin. Oncol., 16, 3412, 10.1200/JCO.1998.16.10.3412 Littlewood, 2001, Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial, J. Clin. Oncol., 19, 2865, 10.1200/JCO.2001.19.11.2865 Gabrilove, 2001, Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients, J. Clin. Oncol., 19, 2875, 10.1200/JCO.2001.19.11.2875 Glaser, 2001, Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx, Int. J. Radiat. Oncol. Biol. Phys., 50, 705, 10.1016/S0360-3016(01)01488-2 Antonadou, 2002, Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies: final results of a randomized phase III study, Eur. J. Cancer, 37, S144